Your browser doesn't support javascript.
loading
Effect of the COVID-19 Pandemic on Rates and Epidemiology of Clostridioides difficile Infection in One VA Hospital.
Wright, Lorinda M; Skinner, Andrew M; Cheknis, Adam; McBurney, Conor; Ge, Ling; Pacheco, Susan M; Leehey, David; Gerding, Dale N; Johnson, Stuart.
Afiliação
  • Wright LM; Edward Hines Jr. VA Hospital, 5000 S. 5th Ave., Hines, IL 60141, USA.
  • Skinner AM; Edward Hines Jr. VA Hospital, 5000 S. 5th Ave., Hines, IL 60141, USA.
  • Cheknis A; Chicago Stritch School of Medicine, Loyola University, 2160 S. First Ave., Maywood, IL 60153, USA.
  • McBurney C; Edward Hines Jr. VA Hospital, 5000 S. 5th Ave., Hines, IL 60141, USA.
  • Ge L; Edward Hines Jr. VA Hospital, 5000 S. 5th Ave., Hines, IL 60141, USA.
  • Pacheco SM; Edward Hines Jr. VA Hospital, 5000 S. 5th Ave., Hines, IL 60141, USA.
  • Leehey D; Edward Hines Jr. VA Hospital, 5000 S. 5th Ave., Hines, IL 60141, USA.
  • Gerding DN; Chicago Stritch School of Medicine, Loyola University, 2160 S. First Ave., Maywood, IL 60153, USA.
  • Johnson S; Edward Hines Jr. VA Hospital, 5000 S. 5th Ave., Hines, IL 60141, USA.
Antibiotics (Basel) ; 12(7)2023 Jul 07.
Article em En | MEDLINE | ID: mdl-37508255
The COVID-19 pandemic was associated with increases in some healthcare-associated infections. We investigated the impact of the pandemic on the rates and molecular epidemiology of Clostridioides difficile infection (CDI) within one VA hospital. We anticipated that the potential widespread use of antibiotics for pneumonia during the pandemic might increase CDI rates given that antibiotics are a major risk for CDI. Hospital data on patients with CDI and recurrent CDI (rCDI) were reviewed both prior to the COVID-19 pandemic (2015 to 2019) and during the pandemic (2020-2021). Restriction endonuclease analysis (REA) strain typing was performed on CD isolates recovered from stool samples collected from October 2019 to March 2022. CDI case numbers declined by 43.2% in 2020 to 2021 compared to the annual mean over the previous 5 years. The stool test positivity rate was also lower during the COVID-19 pandemic (14.3% vs. 17.2%; p = 0.013). Inpatient hospitalization rates declined, and rates of CDI among inpatients were reduced by 34.2% from 2020 to 2021. The mean monthly cases of rCDI also declined significantly after 2020 [3.38 (95% CI: 2.89-3.87) vs. 1.92 (95% CI: 1.27-2.56); p = <0.01]. Prior to the pandemic, REA group Y was the most prevalent CD strain among the major REA groups (27.3%). During the first wave of the pandemic, from 8 March 2020, to 30 June 2020, there was an increase in the relative incidence of REA group BI (26.7% vs. 9.1%); After adjusting for CDI risk factors, a multivariable logistic regression model revealed that the odds of developing an REA group BI CDI increased during the first pandemic wave (OR 6.41, 95% CI: 1.03-39.91) compared to the pre-pandemic period. In conclusion, the incidence of CDI and rCDI decreased significantly during the COVID-19 pandemic. In contrast, REA BI (Ribotype 027), a virulent, previously epidemic CD strain frequently associated with hospital transmission and outbreaks, reappeared as a prevalent strain during the first wave of the pandemic, but subsequently disappeared, and overall CDI rates declined.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article